These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 5739643)

  • 21. [A comparative study of live measles vaccines in controlled epidemiologic trials].
    Donchev D; Arabadzhieva Ts; Zhukovets V; Iancheva B
    Vopr Virusol; 1969; 14(1):104-7. PubMed ID: 4894054
    [No Abstract]   [Full Text] [Related]  

  • 22. Anti-measles vaccines.
    Stones PB
    Rev Invest (Guadalajara); 1965 Apr; 5(1):36-41. PubMed ID: 5829922
    [No Abstract]   [Full Text] [Related]  

  • 23. Studies on the combined use of killed and live measles vaccines. II. Advantages of the inhalation method.
    Okuno Y; Ueda S; Hosai H; Kitawaki T; Nakamura K; Chiang TP; Okabe S; Onaka M; Toyoshima K
    Biken J; 1965 Jun; 8(2):81-5. PubMed ID: 5837767
    [No Abstract]   [Full Text] [Related]  

  • 24. Clinical and serological evaluation of live measles vaccine in India.
    Phadke MA; Rodrigues JJ; Mehta JM; Ayachit V
    Indian Pediatr; 1983 Aug; 20(8):573-6. PubMed ID: 6662582
    [No Abstract]   [Full Text] [Related]  

  • 25. Measles vaccination in HIV-infected children.
    Rose VL; Preboth M
    Am Fam Physician; 1999 Nov; 60(7):2179. PubMed ID: 10569516
    [No Abstract]   [Full Text] [Related]  

  • 26. [Seroconversion following vaccination with a new measles vaccine strain].
    Just M; Wegmann A
    Ther Umsch; 1983 Mar; 40(3):261-3. PubMed ID: 6857567
    [No Abstract]   [Full Text] [Related]  

  • 27. Measles vaccination of macaques by dry powder inhalation.
    de Swart RL; LiCalsi C; Quirk AV; van Amerongen G; Nodelman V; Alcock R; Yüksel S; Ward GH; Hardy JG; Vos H; Witham CL; Grainger CI; Kuiken T; Greenspan BJ; Gard TG; Osterhaus AD
    Vaccine; 2007 Jan; 25(7):1183-90. PubMed ID: 17084489
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Measles: morbidity and effect of the La Espina (Salas) vaccine].
    Lombardero Rico E
    Med Clin (Barc); 1983 Jun; 81(3):95-8. PubMed ID: 6888078
    [No Abstract]   [Full Text] [Related]  

  • 29. Organisation of field trials of vaccines in England with special reference to measles vaccine.
    Pollock TM
    Anglo Ger Med Rev; 1969 Oct; 5():9-12. PubMed ID: 5386890
    [No Abstract]   [Full Text] [Related]  

  • 30. Absence of transmission of the D9 measles virus in the region of the Americas, November 2002 - May 2003.
    Epidemiol Bull; 2003 Mar; 24(1):24. PubMed ID: 15112620
    [No Abstract]   [Full Text] [Related]  

  • 31. Seroconversion after measles vaccination in infants and children.
    Seghal S; Sharma RS; Das A; Sebastian M; Arora RR
    J Commun Dis; 1983 Jun; 15(2):75-9. PubMed ID: 6630988
    [No Abstract]   [Full Text] [Related]  

  • 32. [Measles - 1981].
    Naruszewicz-Lesiuk D
    Przegl Epidemiol; 1983; 37(1):21-9. PubMed ID: 6611980
    [No Abstract]   [Full Text] [Related]  

  • 33. Measles immunization in HIV-infected children. American Academy of Pediatrics. Committee on Infectious Diseases and Committee on Pediatric AIDS.
    Pediatrics; 1999 May; 103(5 Pt 1):1057-60. PubMed ID: 10224192
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vaccination against measles.
    Jonat LV; Snell E
    Manit Med Rev; 1967; 47(7):403-8. PubMed ID: 6056075
    [No Abstract]   [Full Text] [Related]  

  • 35. [Evolution of measles morbidity during the use of a vaccination program].
    Janoşi L; Lucasciuc D; Szabo A
    Viata Med Rev Inf Prof Stiint Cadrelor Medii Sanit; 1984 Nov; 32(11):241-2. PubMed ID: 6442480
    [No Abstract]   [Full Text] [Related]  

  • 36. Rural Kenya: measles during pregnancy and early infancy.
    Arya SC; Agarwal N
    J Infect Dis; 2006 Jan; 193(1):165-6; author reply 166-7. PubMed ID: 16323147
    [No Abstract]   [Full Text] [Related]  

  • 37. [Age-dependence of measles immunization failures].
    Giesecke H; Brendel P; Schmidt J; Schlenk B
    Z Gesamte Hyg; 1980; 26(10):764-67. PubMed ID: 7467503
    [No Abstract]   [Full Text] [Related]  

  • 38. Edmonston B and a further attenuated measles vaccine--a placebo controlled double blind comparison.
    Miller G; Gale J; Villarejos V; James W; Arteaga CG; Casey H; Henderson DA
    Am J Public Health Nations Health; 1967 Aug; 57(8):1333-40. PubMed ID: 4860064
    [No Abstract]   [Full Text] [Related]  

  • 39. [Duration of immunity and delayed skin hypersensitivity in patients vaccinated against measles].
    Veronesi R; Penna HA; Issler H
    Rev Hosp Clin Fac Med Sao Paulo; 1970; 25(1):33-8. PubMed ID: 5422695
    [No Abstract]   [Full Text] [Related]  

  • 40. [The clinical evaluation and immunological response of a new measles vaccine].
    Moretti P; Branciaroli A; Di Battista S; Di Filippo A; Di Pietro M; Calafiore P; Di Battista C
    Minerva Pediatr; 1993 Mar; 45(3):83-6. PubMed ID: 8341231
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.